The literature examining the utility of beta blockers in the setting of acute coronary syndrome (ACS) to limit infarct size has produced conflicting results within and across treatment eras. Animal ...
COMET: Secondary end points show reductions in CVD death and death from stroke with carvedilol vs me
Vienna, Austria - Secondary end points from the recently published Carvedilol or Metoprolol European Trial (COMET) indicate that treatment with the beta blocker carvedilol in patients with heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback